Portfolio

 
Contact:  Lewis Collins, CEO
Website:   www.bioscout.com.au
BioScout was formed by a team of four PhD researchers and honours students at the University of Sydney, and is based on Lewis Collins’ (CEO) PhD work (expected to be submitted 2022). BioScout has since gone through the University’s ‘Incubate’ accelerator and ‘Inventing the Future’ program.
BioScout has developed a device which picks up disease pathogens in crops and indicates the ‘disease load’ across the field in real-time, enabling an early warning system for farmers where yield loss is high. Yield loss to crops is $60B+ in fungal diseases (company’s first focus disease).
BioScout’s technology utilises tried and tested methods of crop pathology and aerobiology but brings modern technology such as robotics and computer vision to automate the processes that have limited pathology to the scientific realm. The direct advantage of the technology is that it can detect airborne diseases in near real-time, 24/7 with complete autonomy.